| Product | Cat. No. | Comments |
| bpV(bipy) | | Blocks insulin receptor dephsophorylation (Ki = 100 nM) and inhibits PTEN (IC50 = 18 nM). |
| bpV(HOpic) | | A potent inhibitor of PTEN (IC50 = 14 nM). |
| bpV(phen) | | A potent inhibitor of PTEN (IC50 = 38 nM). |
| bpV(pic) | | A potent inhibitor of PTEN (IC50 = 31 nM). |
| CDC25 Phosphatase Inhibitor I, BN82002 | | A potent, selective, and irreversible inhibitor of CDC25 phosphatase family (IC50 in mM = 2.4, 3.9, 6.3, 5.4, and 4.6 for 25A, 25B2, 25B3, 25C, and 25C-cat, respectively). |
| Dephostatin | | A competitive PTP inhibitor (IC50 = 7.7 mM). |
| mpV(pic) | | A PTPase inhibitor and an activator of insulin receptor kinase. |
| Phenylarsine Oxide | | A PTP inhibitor (IC50 = 18 mM) that blocks TNF-a-dependent activation of NF-kB in human myeloid ML-1a cells. |
| Protein Tyrosine Phosphatase CD45 Inhibitor | | A cell-permeable, potent, selective, competitive, and reversible inhibitor of CD45 (IC50 = 200 nM using pNPP as substrate). |
| PTP1B Inhibitor | | A selective, reversible and non-competitive allosteric inhibitor of PTP1B (IC50 = 4 mM and 8 mM for PTP1B403 and PTP1B298, respectively). |
| Sodium Orthovanadate | | A broad-spectrum potent inhibitor of PTPases. |
| Sodium Stibogluconate | | An irreversible PTP inhibitor that blocks SHP-1 activity (99% inhibition at ~11 mM). At higher concentrations (~110 mM) also inhibits SHP-2 and PTP1B. |
